Case Report

Bone Marrow Amyloidosis with Erythropoietin-resistant Anemia in a Patient Undergoing Chronic Hemodialysis Treatment

The resistance to erythropoietin, which is used to treat normochromic, normocytic anemia in chronic renal failure, can develop in patients with conditions such as iron deficiency, aluminum toxicity, hyperparathyroidism, chronic inflammatory diseases, and primary hematological disorders. We found amyloidosis in the bone marrow of a woman without any other etiology…